The Relationship Between Bone Morphogenic Protein-4 and Visceral-Central Adiposity

Area of Science:

• Endocrinology
• Metabolic Disorders
• Pediatric Health

Background:

• Excessive fat accumulation, driven by energy imbalance, negatively impacts organs.
• Hepatosteatosis involves visceral fat, while obesity features central fat deposition.
• Understanding molecular markers like BMP-4 is crucial for metabolic health.

Purpose of the Study:

• To investigate bone morphogenetic protein 4 (BMP-4) levels in relation to obesity and hepatosteatosis.
• To determine how BMP-4 expression differs in children with and without obesity and hepatosteatosis.

Main Methods:

• 84 pediatric volunteers were assessed for obesity and hepatosteatosis.
• BMP-4 gene expression was analyzed from peripheral blood RNA.
• Comparisons of BMP-4 levels were made between different weight and hepatosteatosis groups.

Main Results:

• Mean BMP-4 expression was 1.3.
• BMP-4 expression was highest in normal-weight individuals, lowest in overweight, with statistical significance (p=0.024).
• In obese children, BMP-4 showed weak positive correlations with glucose and gamma-glutamyl transpeptidase levels.

Conclusions:

• BMP-4 may modulate obesity and hepatosteatosis.
• BMP-4 expression decreases with initial weight gain but increases in obese individuals.
• Elevated BMP-4 at obesity onset may trigger resistance mechanisms.